Appendices for Receipt of Selected Preventive Health Services for Women and Men of Reproductive Age — United States, 2011–2013

View associated article

Appendix A : Services Recommended in Providing Quality Family Planning Services: Recommendations of CDC and the U.S. Office of Population Affairs

Service Recommendation
Contraceptive services Offer contraceptive services to all clients who wish to delay or prevent pregnancy.
Pregnancy testing and counseling Offer pregnancy testing and counseling to all clients seeking this service.
Achieving pregnancy Advise clients how to achieve pregnancy if they wish to become pregnant and are seeking this service.
Basic infertility services Offer basic infertility services to infertile clients (i.e., those who have failed to achieve pregnancy after 12 mos or longer of regular unprotected intercourse) seeking this service. Earlier assessment may be justified for clients with identified risk factors.
Preconception health services
Folic acid*,† All women planning or capable of pregnancy should be counseled about the need to take a daily supplement containing folic acid.
IPV*,† Screen all women of childbearing age for IPV and provide/refer to intervention services, as indicated.
Alcohol and other drug use Screen clients for use of alcohol and other drugs and provide/refer for behavior counseling, as indicated.
Tobacco use Screen clients for tobacco use and provide/refer for tobacco cessation interventions, as indicated; provide adolescents with interventions to prevent initiation of tobacco use.
Immunizations Screen for immunization status and provide/refer for immunization, as indicated by ACIP: influenza (annually); tetanus (once every 10 yrs); and HPV and hepatitis B (one-time receipt of vaccine series).
Depression Screen all clients for depression when staff-assisted depression care supports are in place to ensure accurate diagnosis, effective treatment, and follow-up. USPSTF notes that the optimum interval for screening for depression is unknown; however, they suggest that a pragmatic approach might be to screen all adults who have not been screened previously and to use clinical judgment in consideration of risk factors, comorbid conditions, and life events to determine whether additional screening of high-risk patients is warranted.
BMI Assess client’s height, weight, and BMI and provide/refer adults with obesity for intensive counseling and behavioral interventions.
Blood pressure At the time QFP was published, the USPSTF recommendation was to screen persons with blood pressure <120/80 mm Hg routinely. For adults who are prehypertensive (i.e., 120–130 mm Hg/80–89 mm Hg), the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure recommends annual screening. AAP recommends annual screening for adolescents. In 2015, USPSTF updated its recommendation on blood pressure screening to indicate that adults at increased risk (i.e., black, with high normal blood pressure, with obesity or overweight, or aged >40 yrs) should be screened every year, while persons at low risk (aged 18–39 yrs with no risk factors) should be screened every 3–5 yrs.
Diabetes At the time QFP was published, the USPSTF recommendation was to screen for type 2 diabetes in asymptomatic adults with sustained blood pressure (either treated or untreated) >135/80 mm Hg. In 2015, USPSTF changed its recommendations to indicate adults aged 40–70 yrs with obesity or overweight should be screened for type 2 diabetes. USPSTF notes that evidence on the optimal rescreening interval for adults with an initial normal glucose test result is limited; however, rescreening every 3 yrs might be a reasonable approach for adults with normal blood glucose levels.
STD services
Chlamydia At the time QFP was published, the CDC recommendation was to screen annually for chlamydia infection all sexually active young females aged ≤25 yrs and among sexually active women aged >25 yrs with risk factors. Screening of male clients can be considered at sites with high prevalence of chlamydia infection and MSM. Recommendations are to provide/refer for treatment, as indicated. In 2015, CDC STD guidelines changed the age for screening all sexually active young women from ≤25 yrs to <25 yrs. Recommendations for women above this age with additional risk factors and male clients remain the same.
Gonorrhea Screen all women at risk for gonorrhea infection annually, including women aged <25 yrs. Screen MSM clients. Provide/refer for treatment, as indicated.
Syphilis Screen persons at risk for syphilis infection, including MSM, commercial sex workers, persons who exchange sex for drugs, persons in adult correctional facilities, and persons living in communities with high prevalence of syphilis.
HIV/AIDS Screen all clients aged 13–64 yrs for HIV/AIDS on a routine basis and rescreen all persons at high risk for HIV infection annually. Refer for care, as indicated.
Hepatitis C Provide one-time testing for hepatitis C infection for persons born during 1945–1965 and routine screening for persons at high risk for hepatitis C infection. Persons with HIV infection should be tested at least annually for hepatitis C infection. Provide/refer for treatment, as indicated.
Related preventive health
Cervical cytology* Screen women aged 21–65 yrs with cervical cytology (Pap smear) every 3 yrs or women aged 30–65 yrs with a combination of cytology and HPV testing every 5 yrs. Refer for further diagnosis and treatment, as indicated.
Breast cancer screening* Screen women aged 50–74 yrs biennially with mammogram; women aged <50 yrs can be considered if other conditions support providing the service. Refer for further diagnosis and treatment, as indicated.

Abbreviations: AAP = American Academy of Pediatrics; ACIP = Advisory Committee on Immunization Practices; BMI = body mass index; HIV/AIDS = human immunodeficiency virus/acquired immunodeficiency syndrome; HPV = human papillomavirus; IPV = intimate partner violence; mm Hg = millimeters of mercury; MSM = men who have sex with men; Pap = Papanicolaou; QFP = Providing Quality Family Planning Services: Recommendations of CDC and the U.S. Office of Population Affairs; USPSTF = U.S. Preventive Services Task Force; STD = sexually transmitted disease.
* This service is only recommended for female clients.
USPSTF has not recommended a screening interval because evidence is lacking to determine the optimal interval.

 

Appendix B : Adverse Health Outcomes Targeted for Prevention Through Services Recommended in Providing Quality Family Planning Services: Recommendations of CDC and the U.S. Office of Population Affairs, by Age

Outcome Total (15–44 yrs)     15–19 yrs 20–24 yrs 25–29 yrs 30–34 yrs 35–39 yrs 40–44 yrs
Unintended pregnancies, 2011*,
No. of unintended pregnancies (in 1,000s) 2,779§ 430 878 691 444 328
Unintended pregnancy (rate per 1,000 population)** 45§ 41 81 66 43 16
Pregnancies unintended (%) 45§ 75 59 42 31 34
Teen births, 2015††
No. of teen births (in 1,000s) N/A 230 N/A N/A N/A N/A N/A
Teen births (rate per 1,000 population)§§ N/A 22.3 N/A N/A N/A N/A N/A
Teen births that are repeat births (%)¶¶ N/A 16.7 N/A N/A N/A N/A N/A
Birth spacing, 2014***
Singleton births conceived <18 mos after previous live birth (%) 28.9††† 22.4§§§ 27.1 29.3 34.9 44.1
Infant health, 2015††
Births that are preterm (%)¶¶¶ 9.6††† 9.9§§§ 9.3 8.9 9.4 11.1 13.7
Births with low birth weight (%)**** 8.1††† 9.5§§§ 8.4 7.5 7.5 8.7 10.8
Infertility, 2011–2013††††, §§§§
Married and cohabiting women (% [95% CI]) 6.3 (4.9–7.7) ¶¶¶¶ 4.9 (1.3–8.5) 5.5 (2.6–8.5) 4.2 (2.4–6.0) 8.5 (4.6–12.3) 8.3 (5.5–11.1)
Obesity, 2011–2012*****
Overweight women (% [95% CI])††††† 25.2 (21.4–29.1) 14.9 (9.7–20.0) 21.7 (14.2–29.3) 29.5 (25.0–33.9)§§§§§ 28.3 (22.4–34.2)¶¶¶¶¶
Obese women (% [95% CI])††††† 30.2 (27.1–33.4) 16.4 (10.0–22.9) 26.9 (18.3–35.5) 34.4 (29.4–39.4)§§§§§ 34.9 (29.9–39.9)¶¶¶¶¶
Hypertension, 2011–2012*****
Women with high blood pressure or medication for high blood pressure (% [95% CI])****** 8.8 (6.8–10.7) 6.4 (4.3–8.5)§§§§§ 19.6 (15.0–24.2)¶¶¶¶¶
Diabetes, 2011–1012*****
Women ever told by health care professional they had diabetes (% [95% CI]s 2.5 (1.7–3.4) 1.2 (0.6–1.8)§§§§§ 5.9 (3.7–8.2)¶¶¶¶¶
Diagnoses of HIV infection, 2014 estimated,†††††† both sexes
No. of diagnoses of HIV infection 32,931 1,854 7,983 7,963 6,093 4,750 4,288
Rate of diagnoses of HIV infection (per 100,000 population) 13.9§§§§§§ 8.7 34.4 35.8 28.0 23.5 20.6
Diagnoses of HIV infection, 2014 estimated,†††††† males
No. of diagnoses of HIV infection 27,371¶¶¶¶¶¶ 1,505 7,083 6,853 4,970 3,659 3,301
Diagnoses of HIV infection, 2014 estimated,†††††† females
No. of diagnoses of HIV infection 5,561 349 901 1,110 1,123 1,091 987
Diagnoses of AIDS, 2014 estimated,******* noncumulative, both sexes
No. of diagnoses of AIDS 12,255 233 1,485 2,555 2,641 2,615 2,726
Rate of diagnoses of AIDS (per 100,000 population) 6.6§§§§§§ 1.1 6.4 11.5 12.1 13.0 13.1
Diagnoses of AIDS, 2014 estimated,¶¶¶¶¶¶ noncumulative, males
No. of diagnoses of AIDS 9,334 166 1,236 2,090 2,013 1,878 1,951
Diagnoses of AIDS, 2014 estimated,¶¶¶¶¶¶ noncumulative, females
No. of diagnoses of AIDS 2,922 68 249 465 628 737 775
STDs, 2014, number and rate, women*******
No. of chlamydia cases reported 981,230 303,294 405,876 161,793 67,060 29,545 13,662
Chlamydia cases reported per 100,000 women 627.2††† 2,941.0 3,651.1 1,523.4 633.7 300.9 130.3
No. of gonorrhea cases reported 156,589 44,399 59,329 28,899 13,988 6,654 3,320
Gonorrhea cases reported per 100,000 women 101.3††† 430.5 533.7 272.1 132.2 67.8 31.7
No. of syphilis cases reported 1,654 262 503 361 248 177 103
Syphilis cases reported per 100,000 women 1.1††† 2.5 4.5 3.4 2.3 1.8 1.0
STDs, 2014, number and rate, men*******
No. of chlamydia cases reported 412,036 77,908 159,804 91,729 45,990 22,894 13,711
Chlamydia cases reported per 100,000 men 278.4††††††† 718.3 1,368.3 837.0 430.6 234.0 132.3
No. of gonorrhea cases reported 169,124 23,981 56,714 40,602 24,349 14,129 9,349
Gonorrhea cases reported per 100,000 men 120.1††††††† 221.1 485.6 370.5 228.0 144.4 90.2
No. of syphilis cases reported 14,277 761 3,632 3,727 2,635 1,868 1,654
Syphilis cases reported per 100,000 men 11.7††††††† 7.0 31.1 34.0 24.7 19.1 16.0

Abbreviations: AIDS = acquired immunodeficiency syndrome; HIV = human immunodeficiency virus; CI = confidence interval; N/A = not applicable; STDs = sexually transmitted diseases.
* Source: Finer LB, Zolna MR. Declines in unintended pregnancy in the United States, 2008–2011. N Engl J Med 2016;374:843–52.
Pregnancies were classified as unintended if they were either mistimed or unwanted; pregnancies were classified as intended if they were desired at the time they occurred or sooner.
§ Includes women aged ≥15 years. Adolescents aged <15 years were excluded because of insufficient data.
Includes women aged ≥35 years.
** Number of unintended pregnancies per 1,000 women aged 15–44 years or specific age group. For women aged ≥35 years, the numerator is the number of unintended pregnancies among women aged ≥35 years and the denominator is the number of women aged 35–44 years.
†† Source: Martin JA, Hamilton BE, Osterman MJK, Driscoll AK, Mathews TJ. Births: final data for 2015. Natl Vital Stat Rep 2017;66:1–69.
§§ Births per 1,000 female teens aged 15–19 years.
¶¶ The percentage of births among teenagers aged 15–19 years that were second or higher order, among all births where birth order was not missing.
*** Source: Thoma ME, Copen CE, Kirmeyer SE. Short interpregnancy intervals in 2014: differences by maternal demographic characteristics. NCHS Data Brief 2016;240:1–8.
††† Includes women of all ages.
§§§ Includes all women aged ≤19 years.
¶¶¶ Less than 37 completed weeks of gestation on the basis of the obstetric estimate.
**** Birth weight <2,500 grams.
†††† Source: National Survey of Family Growth, 2011–2013; special data tabulation.
§§§§ Percentage of all married and cohabiting women aged 15–44 years who are infertile (i.e., who are not surgically sterile and have had at least 12 consecutive months of unprotected sexual intercourse without becoming pregnant).
¶¶¶¶ Does not meet reliability standards.
***** Source: National Health and Nutrition Examination Survey, 2011–2012; special data tabulation.
††††† For women aged 15–19 years, overweight was defined as ≥85th and <95th percentile of body mass index (BMI) for age; obesity was defined as ≥95th percentile. For women aged 20–44 years, overweight was defined as BMI ≥25 and <30; obesity was defined as BMI ≥30.
§§§§§ Includes women aged 25–34 years.
¶¶¶¶¶ Includes women aged 35–44 years.
****** For women aged 15–19 years, hypertension was defined as ≥95th percentile systolic or diastolic blood pressure given age and height percentile or use of medication to control blood pressure. For women aged 20–44 years, hypertension was defined as ≥140 mm Hg systolic blood pressure, ≥90 mm Hg diastolic blood pressure, or use of medication to control blood pressure.
†††††† Source: National HIV Surveillance System. Data include persons with a diagnosis of HIV infection regardless of stage of disease at diagnosis. The estimated numbers and rates of diagnoses of HIV infection were made on the basis of data from 50 states and six dependent areas. Estimated numbers resulted from statistical adjustment that accounted for reporting delays and missing risk-factor information, but not for incomplete reporting. CDC. HIV surveillance report, 2014; vol. 26. https://www.cdc.gov/hiv/pdf/library/reports/surveillance/cdc-hiv-surveillance-report-2014-vol-26.pdf (Tables 1b and 5b).
§§§§§§ Includes women and men of all ages.
¶¶¶¶¶¶ Source: National HIV Surveillance System. The estimated numbers and rates of stage 3 infection (AIDS) were made on the basis of data from 50 states and six dependent areas. Estimated numbers resulted from statistical adjustment that accounted for reporting delays and missing risk-factor information, but not for incomplete reporting. CDC. HIV Surveillance Report, 2014; vol. 26. https://www.cdc.gov/hiv/pdf/library/reports/surveillance/cdc-hiv-surveillance-report-2014-vol-26.pdf (Tables 2b and 6b).
******* Source: Nationally Notifiable Disease Surveillance System. 2014 sexually transmitted disease surveillance report. Chlamydia: https://www.cdc.gov/std/stats14/tables/10.htm; gonorrhea: https://www.cdc.gov/std/stats14/tables/21.htm; and syphilis: https://www.cdc.gov/std/stats14/tables/35.htm.
††††††† Includes men of all ages.

Top


MMWR and Morbidity and Mortality Weekly Report are service marks of the U.S. Department of Health and Human Services.
Use of trade names and commercial sources is for identification only and does not imply endorsement by the U.S. Department of Health and Human Services.
References to non-CDC sites on the Internet are provided as a service to MMWR readers and do not constitute or imply endorsement of these organizations or their programs by CDC or the U.S. Department of Health and Human Services. CDC is not responsible for the content of pages found at these sites. URL addresses listed in MMWR were current as of the date of publication.

All HTML versions of MMWR articles are generated from final proofs through an automated process. This conversion might result in character translation or format errors in the HTML version. Users are referred to the electronic PDF version (https://www.cdc.gov/mmwr) and/or the original MMWR paper copy for printable versions of official text, figures, and tables.

Questions or messages regarding errors in formatting should be addressed to mmwrq@cdc.gov.

View Page In: PDF [391K]